Killer cell dynamics: Mathematical and computational approaches to immunology

Interdisciplinary Applied Mathematics

Volumn 32, Issue , 2007, Pages 1-220

  Wodarz, Dominik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85097994371     PISSN: 09396047     EISSN: 21969973     Source Type: Book Series    
DOI: None     Document Type: Chapter

References (305)

1. Adorini, L., Appella, E., Doria, G.,Nagy, Z.A.: Mechanisms Influencing the Immunodominance of T-Cell Determinants. Journal of Experimental Medicine 168, 2091-2104 (1988)
2. Ahmed, R., Butler, L.D.,Bhatti, L.: T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J Virol 62, 2102-6 (1988)
3. Ahmed, R.,Gray, D.: Immunological memory and protective immunity: understanding their relation. Science 272, 54-60 (1996)
4. Ahmed, R.,Oldstone, M.B.: Organ-specific selection of viral variants during chronic infection. J Exp Med 167, 1719-24 (1988)
5. Andersen, C., Jensen, T., Nansen, A., Marker, O., Thomsen, A.R.: CD4(+) T cell-mediated protection against a lethal outcome of systemic infection with vesicular stomatitis virus requires CD40 ligand expression, but not IFN-gamma or IL-4. Int Immunol 11, 2035-42. (1999)
6. Anderson, R.M.,May, R.M. Infectious diseases of humans. Oxofrd, England: Oxfors University Press(1991)
7. Andersson, E.C., Christensen, J.P., Marker, O.,Thomsen, A.R.: Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J Immunol 152, 1237-45 (1994)
8. Andreasen, S.O., Christensen, J.E., Marker, O.,Thomsen, A.R.: Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses. J Immunol 164, 3689-97 (2000)
9. Andreasen, V., Lin, J.,Levin, S.A.: The dynamics of cocirculating influenza strains conferring partial cross-immunity. J Math Biol 35, 825-42. (1997)
10. Arase, H.,Lanier, L.L.: Virus-driven evolution of natural killer cell receptors. Microbes Infect 4, 1505-12 (2002)
11. Arnaout, R.A.,Nowak, M.A.: Competitive coexistence in antiviral immunity. J Theor Biol 204, 431-41. (2000)
12. Bachmann, M.F., Kalinke, U., Althage, A., Freer, G., Burkhart, C., Roost, H., Aguet, M., Hengartner, H.,Zinkernagel, R.M.: The role of antibody concentration and avidity in antiviral protection. Science 276, 2024-7 (1997)
13. Badovinac, V.P., Porter, B.B.,Harty, J.T.: Programmed contraction of CD8(+) T cells after infection. Nat Immunol 3, 619-26. (2002)
14. Badovinac, V.P., Tvinnereim, A.R.,Harty, J.T.: Regulation of Antigen-Specific CD8(+) T Cell Homeostasis by Perforin and Interferon-gamma. Science 290, 1354-1358 (2000)
15. Bangham, C.R.: Human T-cell leukaemia virus type I and neurological disease. Curr Opin Neurobiol 3, 773-8 (1993)
16. Bangham, C.R.M., Hall, S.E., Jeffrey, K.J.M, Vine, A.M., Witkover, A., Nowak, M.A., Wodarz, D., Usuku, K., Osame, M.: Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-1. Philosophical Transactions of the Royal Society, Series B 354, 691-700 (1999)
17. Barclay, W.S., al-Nakib, W., Higgins, P.G., Tyrrell, D.A.: The time course of the humoral immune response to rhinovirus infection. Epidemiol Infect 103, 659-69. (1989)
18. Barnes, E., Harcourt, G., Brown, D., Lucas, M., Phillips, R., Dusheiko, G.,Klenerman, P.: The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36, 743-54. (2002)
19. Bartholdy, C., Christensen, J.P., Wodarz, D.,Thomsen, A.R.: Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus. J Virol 74, 10304-11 (2000)
20. Belz, G.T., Wodarz, D., Diaz, G., Nowak, M.A.,Doherty, P.C.: Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 76, 12388-93. (2002)
21. Bergmann, C.C., Altman, J.D., Hinton, D.,Stohlman, S.A.: Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol 163, 3379-87 (1999)
22. Betts, M.R., Ambrozak, D.R., Douek, D.C., Bonhoeffer, S., Brenchley, J.M., Casazza, J.P., Koup, R.A.,Picker, L.J.: Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol 75, 11983-91 (2001)
23. Beverley, P.C.: Is T-cell memory maintained by crossreactive stimulation? Immunol Today 11, 203-5 (1990)
24. Binder, D., van den Broek, M.F., Kagi, D., Bluethmann, H., Fehr, J., Hengartner, H.,Zinkernagel, R.M.: Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus. J Exp Med 187, 1903-20. (1998)
25. Bocharov, G., Ludewig, B., Bertoletti, A., Klenerman, P., Junt, T., Krebs, P., Luzyanina, T., Fraser, C.,Anderson, R.M.: Underwhelming the immune response: effect of slow virus growth on CD8+-T-lymphocyte responses. J Virol 78, 2247-54 (2004)
26. Bonhoeffer, S., May, R.M., Shaw, G.M.,Nowak, M.A.: Virus dynamics and drug therapy. Proceedings of the National Academy of Sciences of the United States of America 94, 6971-6976 (1997)
27. Bonhoeffer, S.,Nowak, M.A.: Pre-existence and emergence of drug resistance in HIV-1 infection. Proc R Soc Lond B Biol Sci 264, 631-7 (1997)
28. Boni, C., Penna, A., Ogg, G.S., Bertoletti, A., Pilli, M., Cavallo, C., Cavalli, A., Urbani, S., Boehme, R., Panebianco, R., Fiaccadori, F.,Ferrari, C.: Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33, 963-71. (2001)
29. Borghans, J.A., Taams, L.S., Wauben, M.H.,de Boer, R.J.: Competition for antigenic sites during T cell proliferation: a mathematical interpretation of in vitro data. Proc Natl Acad Sci U S A 96, 10782-7. (1999)
30. Borrow, P., Evans, C.F.,Oldstone, M.B.: Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol 69, 1059-70 (1995)
31. Borrow, P., Lewicki, H., Wei, X.P., Horwitz, M.S., Peffer, N., Meyers, H., Nelson, J.A., Gairin, J.E., Hahn, B.H., Oldstone, M.B.A., Shaw, G.M.: Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Medicine 3, 205-211 (1997)
32. Borrow, P., Tishon, A., Lee, S., Xu, J., Grewal, I.S., Oldstone, M.B., Flavell, R.A.: CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med 183, 2129-42 (1996)
33. Borrow, P., Tough, D.F., Eto, D., Tishon, A., Grewal, I.S., Sprent, J., Flavell, R.A.,Oldstone, M.B.: CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J Virol 72, 7440-9 (1998)
34. Brehm, M.A., Pinto, A.K., Daniels, K.A., Schneck, J.P., Welsh, R.M., Selin, L.K.: T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 3, 627-34 (2002)
35. Broussard, S.R., Staprans, S.I., White, R., Whitehead, E.M., Feinberg, M.B., Allan, J.S.: Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J Virol 75, 2262-75 (2001)
36. Bruno, L., Kirberg, J.,von Boehmer, H.: On the cellular basis of immunological T cell memory. Immunity 2, 37-43 (1995)
37. Cabot, B., Martell, M., Esteban, J.I., Sauleda, S., Otero, T., Esteban, R., Guardia, J.,Gomez, J.: Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J Virol 74, 805-11. (2000)
38. Carayannopoulos, L.N.,Yokoyama, W.M.: Recognition of infected cells by natural killer cells. Curr Opin Immunol 16, 26-33 (2004)
39. Chang, K.M., Rehermann, B.,Chisari, F.V.: Immunopathology of hepatitis C. Springer Semin Immunopathol 19, 57-68 (1997)
40. Chang, K.M., Thimme, R., Melpolder, J.J., Oldach, D., Pemberton, J., Moorhead-Loudis, J., McHutchison, J.G., Alter, H.J.,Chisari, F.V.: Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 33, 267-76. (2001)
41. Chen, W., Anton, L.C., Bennink, J.R.,Yewdell, J.W.: Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12, 83-93 (2000)
42. Christensen, J.E., Wodarz, D., Christensen, J.P.,Thomsen, A.R.: Perforin and IFN gamma do not significantly regulate the virus-specific CD8+ T cell response in the absence of antiviral effector activity. European Journal of Immunology 34, 1389-1394 (2004)
43. Christensen, J.P., Bartholdy, C., Wodarz, D.,Thomsen, A.R.: Depletion of CD4+ T cells precipitates immunopathology in immunodeficient mice infected with a noncytocidal virus. J Immunol 166, 3384-91. (2001)
44. Christensen, J.P., Cardin, R.D., Branum, K.C.,Doherty, P.C.: CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci U S A 96, 5135-40 (1999)
45. Chun, T.W., Stuyver, L., Mizell, S.B., Ehler, L.A., Mican, J.A., Baseler, M., Lloyd, A.L., Nowak, M.A.,Fauci, A.S.: Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 94, 13193-7 (1997)
46. Ciurea, A., Klenerman, P., Hunziker, L., Horvath, E., Senn, B.M., Ochsenbein, A.F., Hengartner, H.,Zinkernagel, R.M.: Viral persistence in vivo through selection of neutralizing antibody-escape variants. Proc Natl Acad Sci U S A 97, 2749-54. (2000)
47. Cocchi, F., DeVico, A.L., Garzino-Demo, A., Arya, S.K., Gallo, R.C., Lusso, P.: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-5 (1995)
48. Condra, J.H., Schleif, W.A., Blahy, O.M., Gabryelski, L.J., Graham, D.J., Quintero, J.C., Rhodes, A., Robbins, H.L., Roth, E., Shivaprakash, M.,et al.: In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374, 569-71 (1995)
49. Cooper, S., Erickson, A.L., Adams, E.J., Kansopon, J., Weiner, A.J., Chien, D.Y., Houghton, M., Parham, P.,Walker, C.M.: Analysis of a successful immune response against hepatitis C virus. Immunity 10, 439-49. (1999)
50. Curran, R., Jameson, C.L., Craggs, J.K., Grabowska, A.M., Thomson, B.J., Robins, A., Irving, W.L.,Ball, J.K.: Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity. J Gen Virol 83, 11-23. (2002)
51. Davenport, M.P.: Benefits of memory. Nat Immunol 1, 451. (2000)
52. Day, C.L., Lauer, G.M., Robbins, G.K., McGovern, B., Wurcel, A.G., Gandhi, R.T., Chung, R.T.,Walker, B.D.: Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76, 12584-95 (2002)
53. de Araujo, E.S., Cavalheiro Nde, P., Cubero Leitao, R.M., Borges Tosta, R.A.,Barone, A.A.: Hepatitis C viral load does not predict disease outcome: going beyond numbers. Rev Inst Med Trop Sao Paulo 44, 71-8. (2002)
54. de Boer, R.J.,Boerlijst, M.C.: Diversity and virulence thresholds in AIDS. Proc Natl Acad Sci U S A 91, 544-8 (1994)
55. De Boer, R.J.,Perelson, A.S.: T cell repertoires and competitive exclusion. J Theor Biol 169, 375-90 (1994)
56. De Boer, R.J.,Perelson, A.S.: Towards a general function describing T cell proliferation. J Theor Biol 175, 567-76. (1995)
57. De Boer, R.J.,Perelson, A.S.: Target cell limited and immune control models of HIV infection: a comparison. J Theor Biol 190, 201-14 (1998)
58. Deeths, M.J., Kedl, R.M.,Mescher, M.F.: CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. J Immunol 163, 102-10 (1999)
59. Doherty, P.C., Topham, D.J.,Tripp, R.A.: Establishment and persistence of virus-specific CD4+ and CD8+ T cell memory. Immunol Rev 150, 23-44 (1996)
60. Doherty, P.C., Topham, D.J., Tripp, R.A., Cardin, R.D., Brooks, J.W., Stevenson, P.G.: Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159, 105-17 (1997)
61. Dokun, A.O., Kim, S., Smith, H.R., Kang, H.S., Chu, D.T.,Yokoyama, W.M.: Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2, 951-6 (2001)
62. Douek, D.C., Brenchley, J.M., Betts, M.R., Ambrozak, D.R., Hill, B.J., Okamoto, Y., Casazza, J.P., Kuruppu, J., Kunstman, K., Wolinsky, S., Grossman, Z., Dybul, M., Oxenius, A., Price, D.A., Connors, M.,Koup, R.A.: HIV preferentially infects HIV-specific CD4+ T cells. Nature 417, 95-8. (2002)
63. Effros, R.B.,Walford, R.L.: Diminished T-cell response to influenza virus in aged mice. Immunology 49, 387-92 (1983)
64. Ehl, S., Klenerman, P., Aichele, P., Hengartner, H.,Zinkernagel, R.M.: A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur J Immunol 27, 3404-13 (1997)
65. Eichelberger, M., Allan, W., Zijlstra, M., Jaenisch, R.,Doherty, P.C.: Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med 174, 875-80 (1991)
66. Fagiolo, U., Amadori, A., Cozzi, E., Bendo, R., Lama, M., Douglas, A.,Palu, G.: Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging (Milano) 5, 451-8 (1993)
67. Farci, P.: Hepatitis C virus. The importance of viral heterogeneity. Clin Liver Dis 5, 895-916. (2001)
68. Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J.C., Strazzera, A., Chien, D.Y., Munoz, S.J., Balestrieri, A., Purcell, R.H.,Alter, H.J.: The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-44 (2000)
69. Finzi, D., Hermankova, M., Pierson, T., Carruth, L.M., Buck, C., Chaisson, R.E., Quinn, T.C., Chadwick, K., Margolick, J., Brookmeyer, R., Gallant, J., Markowitz, M., Ho, D.D., Richman, D.D.,Siliciano, R.F.: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295-300 (1997)
70. Fishman, M.A.,Perelson, A.S.: Modeling T cell-antigen presenting cell interactions. J Theor Biol 160, 311-42. (1993)
71. Flemington, E.K.: Herpesvirus lytic replication and the cell cycle: arresting new developments. J Virol 75, 4475-81 (2001)
72. Forns, X., Purcell, R.H.,Bukh, J.: Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol 7, 402-10. (1999)
73. Freitas, A.A.,Rocha, B.: Population biology of lymphocytes: the flight for survival. Annu Rev Immunol 18, 83-111 (2000)
74. French, A.R.,Yokoyama, W.M.: Natural killer cells and viral infections. Curr Opin Immunol 15, 45-51 (2003)
75. Frost, S.D.,McLean, A.R.: Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection. Aids 8, 323-32 (1994)
76. Fujinami, R.S.: Viruses and autoimmune disease–two sides of the same coin? Trends Microbiol 9, 377-81. (2001)
77. Gallo, R.C., Lusso, P.: Chemokines and HIV infection. Current Opinion of Infectious Diseases 10, 12-17 (1997)
78. Garcia, F., Plana, M., Ortiz, G.M., Bonhoeffer, S., Soriano, A., Vidal, C., Cruceta, A., Arnedo, M., Gil, C., Pantaleo, G., Pumarola, T., Gallart, T., Nixon, D.F., Miro, J.M.,Gatell, J.M.: The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. Aids 15, F29-40. (2001)
79. Gerhard, W., Mozdzanowska, K., Furchner, M., Washko, G.,Maiese, K.: Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol Rev 159, 95-103 (1997)
80. Gern, J.E., Joseph, B., Galagan, D.M., Borcherding, W.R.,Dick, E.C.: Rhinovirus inhibits antigen-specific T cell proliferation through an intercellular adhesion molecule-1-dependent mechanism. J Infect Dis 174, 1143-50. (1996)
81. Goon, P.K., Biancardi, A., Fast, N., Igakura, T., Hanon, E., Mosley, A.J., Asquith, B., Gould, K.G., Marshall, S., Taylor, G.P., Bangham, C.R.: Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis 189, 2294-8 (2004)
82. Goulder, P.J., Phillips, R.E., Colbert, R.A., McAdam, S., Ogg, G., Nowak, M.A., Giangrande, P., Luzzi, G., Morgan, B., Edwards, A., McMichael, A.J.,Rowland-Jones, S.: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3, 212-7 (1997a)
83. Goulder, P.J., Sewell, A.K., Lalloo, D.G., Price, D.A., Whelan, J.A., Evans, J., Taylor, G.P., Luzzi, G., Giangrande, P., Phillips, R.E.,McMichael, A.J.: Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J Exp Med 185, 1423-33 (1997b)
84. Goulder, P.J.R., Phillips, R.E., Colbert, R.A., McAdam, S., Ogg, G., Nowak, M.A., Giangrande, P., Luzzi, G., Morgan, B., Edwards, A., McMichael, A.J.,RowlandJones, S.: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Medicine 3, 212-217 (1997c)
85. Gray, D.,Matzinger, P.: T cell memory is short-lived in the absence of antigen. J Exp Med 174, 969-74 (1991)
86. Groarke, J.M.,Pevear, D.C.: Attenuated virulence of pleconaril-resistant cox-sackievirus B3 variants. J Infect Dis 179, 1538-41. (1999)
87. Guidotti, L.G., Ando, K., Hobbs, M.V., Ishikawa, T., Runkel, L., Schreiber, R.D.,Chisari, F.V.: Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A 91, 3764-8 (1994a)
88. Guidotti, L.G., Ando, K., Hobbs, M.V., Ishikawa, T., Runkel, L., Schreiber, R.D.,Chisari, F.V.: Cytotoxic T-Lymphocytes Inhibit Hepatitis-B Virus Gene-Expression By a Noncytolytic Mechanism in Transgenic Mice. Proceedings of the National Academy of Sciences of the United States of America 91, 3764-3768 (1994b)
89. Guidotti, L.G., Borrow, P., Brown, A., McClary, H., Koch, R.,Chisari, F.V.: Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med 189, 1555-64 (1999a)
90. Guidotti, L.G.,Chisari, F.V.: To Kill or to Cure-Options in Host-Defense Against Viral-Infection. Current Opinion in Immunology 8, 478-483 (1996)
91. Guidotti, L.G., Ishikawa, T., Hobbs, M.V., Matzke, B., Schreiber, R.,Chisari, F.V.: Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4, 25-36 (1996a)
92. Guidotti, L.G., Ishikawa, T., Hobbs, M.V., Matzke, B., Schreiber, R.,Chisari, F.V.: Intracellular Inactivation of the Hepatitis-B Virus By Cytotoxic T-Lymphocytes. Immunity 4, 25-36 (1996b)
93. Guidotti, L.G., Rochford, R., Chung, J., Shapiro, M., Purcell, R.,Chisari, F.V.: Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825-9 (1999b)
94. Gupta, S.,Anderson, R.M.: Population structure of pathogens: the role of immune selection. Parasitol Today 15, 497-501 (1999)
95. Harrer, T., Harrer, E., Kalams, S.A., Barbosa, P., Trocha, A., Johnson, R.P., Elbeik, T., Feinberg, M.B., Buchbinder, S.P.,Walker, B.D.: Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol 156, 2616-23 (1996a)
96. Harrer, T., Harrer, E., Kalams, S.A., Elbeik, T., Staprans, S.I., Feinberg, M.B., Cao, Y., Ho, D.D., Yilma, T., Caliendo, A.M., Johnson, R.P., Buchbinder, S.P.,Walker, B.D.: Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses 12, 585-92 (1996b)
97. Heinzinger, N.K., Bukinsky, M.I., Haggerty, S.A., Ragland, A.M., Kewalra-mani, V., Lee, M.A., Gendelman, H.E., Ratner, L., Stevenson, M.,Emerman, M.: The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A 91, 7311-5 (1994)
98. Heise, M.T., Connick, M.,Virgin, H.W.t.: Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J Exp Med 187, 1037-46 (1998a)
99. Heise, M.T., Pollock, J.L., O’Guin, A., Barkon, M.L., Bormley, S.,Virgin, H.W.t.: Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon. Virology 241, 331-44 (1998b)
100. Hendley, J.O.: Clinical virology of rhinoviruses. Adv Virus Res 54, 453-66 (1999)
101. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M., Markowitz, M.: Rapid Turnover of Plasma Virions and Cd4 Lymphocytes in Hiv-1 Infection. Nature 373, 123-126 (1995)
102. Hoffman, G.W.: A theory of regulation and self-non-self discrumunation in an immune network. European Journal of Immunology 5, 638-657 (1975)
103. Holtappels, R., Podlech, J., Pahl-Seibert, M.F., Julch, M., Thomas, D., Simon, C.O., Wagner, M.,Reddehase, M.J.: Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med 199, 131-6 (2004)
104. Hou, S., Hyland, L., Ryan, K.W., Portner, A.,Doherty, P.C.: Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature 369, 652-4 (1994)
105. Hummel, M.,Abecassis, M.M.: A model for reactivation of CMV from latency. J Clin Virol 25 Suppl 2, S123-36 (2002)
106. Jamieson, B.D.,Ahmed, R.: T cell memory. Long-term persistence of virus-specific cytotoxic T cells. J Exp Med 169, 1993-2005 (1989)
107. Janssen, E.M., Lemmens, E.E., Wolfe, T., Christen, U., von Herrath, M.G., Schoenberger, S.P.: CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421, 852-6 (2003)
108. Jeffery, K.J., Usuku, K., Hall, S.E., Matsumoto, W., Taylor, G.P., Procter, J., Bunce, M., Ogg, G.S., Welsh, K.I., Weber, J.N., Lloyd, A.L., Nowak, M.A., Nagai, M., Kodama, D., Izumo, S., Osame, M.,Bangham, C.R.: HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 96, 3848-53 (1999)
109. Jerne, N.K.: Clonal selection in a lymphocyte network. Soc Gen Physiol Ser 29, 39-48 (1974a)
110. Jerne, N.K.: Towards a network theory of the immune system. Ann Immunol (Paris) 125C, 373-89 (1974b)
111. Kaech, S.M.,Ahmed, R.: Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2, 415-22. (2001)
112. Kaech, S.M., Hemby, S., Kersh, E.,Ahmed, R.: Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111, 837-51 (2002)
113. Kagi, D., Hengartner, H.: Different Roles For Cytotoxic T-Cells in the Control of Infections With Cytopathic Versus Noncytopathic Viruses. Current Opinion in Immunology 8, 472-477 (1996)
114. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R.M., Hengartner, H.: Lymphocyte-Mediated Cytotoxicity in-Vitro and in-Vivo-Mechanisms and Significance. Immunological Reviews 146, 95-115 (1995a)
115. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R.M.,Hengartner, H.: Molecular Mechanisms of Lymphocyte-Mediated Cytotoxicity and Their Role in Immunological Protection and Pathogenesis in-Vivo. Annual Review of Immunology 14, 207-232 (1996)
116. Kagi, D., Seiler, P., Pavlovic, J., Ledermann, B., Burki, K., Zinkernagel, R.M.,Hengartner, H.: The Roles of Perforin-Dependent and Fas-Dependent Cytotoxicity in Protection Against Cytopathic and Noncytopathic Viruses. European Journal of Immunology 25, 3256-3262 (1995b)
117. Kalams, S.A., Goulder, P.J., Shea, A.K., Jones, N.G., Trocha, A.K., Ogg, G.S.,Walker, B.D.: Levels of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Effector and Memory Responses Decline after Suppression of Viremia with Highly Active Antiretroviral Therapy. J Virol 73, 6721-6728 (1999)
118. Karrer, U., Sierro, S., Wagner, M., Oxenius, A., Hengel, H., Koszinowski, U.H., Phillips, R.E., Klenerman, P.: Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol 170, 2022-9 (2003)
119. Kaufmann, D.E., Lichterfeld, M., Altfeld, M., Addo, M.M., Johnston, M.N., Lee, P.K., Wagner, B.S., Kalife, E.T., Strick, D., Rosenberg, E.S.,Walker, B.D.: Limited durability of viral control following treated acute HIV infection. PLoS Med 1, e36 (2004)
120. Kaur, A., Daniel, M.D., Hempel, D., Lee-Parritz, D., Hirsch, M.S., Johnson, R.P.: Cytotoxic T-lymphocyte responses to cytomegalo-virus in normal and simian immunodeficiency virus-infected rhesus macaques. J Virol 70, 7725-33 (1996)
121. King, C.C., de Fries, R., Kolhekar, S.R.,Ahmed, R.: In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection. J Virol 64, 5611-6 (1990)
122. Klavinskis, L.S., Geckeler, R.,Oldstone, M.B.: Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo. J Gen Virol 70, 3317-25. (1989)
123. Klenerman, P., Lechner, F., Kantzanou, M., Ciurea, A., Hengartner, H., Zinkernagel, R.: Viral escape and the failure of cellular immune responses. Science 289, 2003. (2000)
124. Klenerman, P., Meier, U.C., Phillips, R.E.,McMichael, A.J.: The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur J Immunol 25, 1927-31 (1995)
125. Klenerman, P., Phillips, R.E., Rinaldo, C.R., Wahl, L.M., Ogg, G., May, R.M., McMichael, A.J.,Nowak, M.A.: Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci U S A 93, 15323-8 (1996)
126. Komarova, N.L., Barnes, E., Klenerman, P.,Wodarz, D.: Boosting immunity by antiviral drug therapy: a simple relationship among timing, efficacy, and success. Proc Natl Acad Sci U S A 100, 1855-60 (2003)
127. Komatsu, H., Sierro, S., A, V.C., Klenerman, P.: Population analysis of antiviral T cell responses using MHC class I-peptide tetramers. Clin Exp Immunol 134, 9-12 (2003)
128. Krakauer, D.C.,Nowak, M.: T-cell induced pathogenesis in HIV: bystander effects and latent infection. Proc R Soc Lond B Biol Sci 266, 1069-75 (1999)
129. Kundig, T.M., Bachmann, M.F., Oehen, S., Hoffmann, U.W., Simard, J.J., Kalberer, C.P., Pircher, H., Ohashi, P.S., Hengartner, H., Zinkernagel, R.M.: On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci U S A 93, 9716-23 (1996a)
130. Kundig, T.M., Bachmann, M.F., Ohashi, P.S., Pircher, H., Hengartner, H., Zinkernagel, R.M.: On T cell memory: arguments for antigen dependence. Immunol Rev 150, 63-90 (1996b)
131. Larder, B.A., Darby, G.,Richman, D.D.: HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243, 1731-4 (1989)
132. Lau, L.L., Jamieson, B.D., Somasundaram, T.,Ahmed, R.: Cytotoxic T-cell memory without antigen. Nature 369, 648-52 (1994)
133. Layden, T.J., Lam, N.P.,Wiley, T.E.: Hepatitis C viral dynamics. Clin Liver Dis 3, 793-810. (1999)
134. Layden, T.J., Mika, B.,Wiley, T.E.: Hepatitis C kinetics: mathematical modeling of viral response to therapy. Semin Liver Dis 20, 173-83 (2000)
135. Lechner, F., Gruener, N.H., Urbani, S., Uggeri, J., Santantonio, T., Kammer, A.R., Cerny, A., Phillips, R., Ferrari, C., Pape, G.R., Klenerman, P.: CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 30, 2479-87. (2000a)
136. Lechner, F., Sullivan, J., Spiegel, H., Nixon, D.F., Ferrari, B., Davis, A., Borkowsky, B., Pollack, H., Barnes, E., Dusheiko, G.,Klenerman, P.: Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers. Philos Trans R Soc Lond B Biol Sci 355, 1085-92. (2000b)
137. Lechner, F., Wong, D.K., Dunbar, P.R., Chapman, R., Chung, R.T., Dohren-wend, P., Robbins, G., Phillips, R., Klenerman, P.,Walker, B.D.: Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191, 1499-512 (2000c)
138. Lehmann-Grube, F.: Lymphocytic choriomeningitis virus. Virol. Monogr. 10, 1-173 (1971)
139. Levin, S.A., Grenfell, B., Hastings, A.,Perelson, A.S.: Mathematical and computational challenges in population biology and ecosystems science. Science 275, 334-343 (1997)
140. Levy, J.A., Mackewicz, C.E.,Barker, E.: Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 17, 217-24 (1996)
141. Lifson, J.D., Rossio, J.L., Arnaout, R., Li, L., Parks, T.L., Schneider, D.M., Kiser, R.F., Coalter, V.J., Walsh, G., Imming, R., Fischer, B., Flynn, B.M., Nowak, M.A.,Wodarz, D.: Containment of SIV infection: cellular immune responses and protection from rechallenge following transient post-inoculation antiretroviral treatment. J. Virol. 74, 2584-93 (2000)
142. Lifson, J.D., Rossio, J.L., Piatak, M., Jr., Parks, T., Li, L., Kiser, R., Coalter, V., Fisher, B., Flynn, B.M., Czajak, S., Hirsch, V.M., Reimann, K.A., Schmitz, J.E., Ghrayeb, J., Bischofberger, N., Nowak, M.A., Desrosiers, R.C.,Wodarz, D.: Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol 75, 10187-99. (2001)
143. Lin, J., Andreasen, V.,Levin, S.A.: Dynamics of influenza A drift: the linear three-strain model. Math Biosci 162, 33-51. (1999)
144. Lipsitch, M.,Moxon, E.R.: Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol 5, 31-7. (1997)
145. Lisziewicz, J.,Lori, F.: Structured treatment interruptions in HIV/AIDS therapy. Microbes Infect 4, 207-14. (2002)
146. Little, S.J., McLean, A.R., Spina, C.A., Richman, D.D.,Havlir, D.V.: Viral dynamics of acute HIV-1 infection. J Exp Med 190, 841-50. (1999)
147. Liu, H., Andreansky, S., Diaz, G., Turner, S.J., Wodarz, D.,Doherty, P.C.: Quantitative analysis of long-term virus-specific CD8+-T-cell memory in mice challenged with unrelated pathogens. J Virol 77, 7756-63 (2003)
148. Lori, F., Lewis, M.G., Xu, J., Varga, G., Zinn, D.E., Jr., Crabbs, C., Wagner, W., Greenhouse, J., Silvera, P., Yalley-Ogunro, J., Tinelli, C.,Lisziewicz, J.: Control of SIV rebound through structured treatment interruptions during early infection. Science 290, 1591-3. (2000a)
149. Lori, F., Maserati, R., Foli, A., Seminari, E., Timpone, J.,Lisziewicz, J.: Structured treatment interruptions to control HIV-1 infection. Lancet 355, 287-8. (2000b) hskip-1.0cm
150. Lotka, A.J. Elements of Mathematical Biology. Dover, New York: Dover Pubns(1956)
151. Lyra, A.C., Fan, X., Lang, D.M., Yusim, K., Ramrakhiani, S., Brunt, E.M., Korber, B., Perelson, A.S.,Di Bisceglie, A.M.: Evolution of hepatitis C viral quasispecies after liver transplantation. Gastroenterology 123, 1485-93. (2002)
152. Major, M.E., Mihalik, K., Fernandez, J., Seidman, J., Kleiner, D., Kolykhalov, A.A., Rice, C.M.,Feinstone, S.M.: Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol 73, 3317-25. (1999)
153. Manjunath, N., Shankar, P., Wan, J., Weninger, W., Crowley, M.A., Hieshima, K., Springer, T.A., Fan, X., Shen, H., Lieberman, J.,von Andrian, U.H.: Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest 108, 871-8 (2001)
154. Manzin, A., Solforosi, L., Giostra, F., Bianchi, F.B., Bruno, S., Rossi, S., Gabrielli, A., Candela, M., Petrelli, E.,Clementi, M.: Quantitative analysis of hepatitis C virus activity in vivo in different groups of untreated patients. Arch Virol 142, 465-72 (1997)
155. Matloubian, M., Suresh, M., Glass, A., Galvan, M., Chow, K., Whitmire, J.K., Walsh, C.M., Clark, W.R.,Ahmed, R.: A role for perforin in downregulat-ing T-cell responses during chronic viral infection. J Virol 73, 2527-36 (1999)
156. Matzinger, P.: An innate sense of danger. Semin Immunol 10, 399-415. (1998)
157. McAdam, S., Klenerman, P., Tussey, L., Rowland-Jones, S., Lalloo, D., Phillips, R., Edwards, A., Giangrande, P., Brown, A.L., Gotch, F.,et al.: Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J Immunol 155, 2729-36 (1995)
158. McMichael, A., Goulder, P., Rowlandjones, S., Nowak, M.,Phillips, R.: Hiv Escapes From Cytoxic Lymphocytes. Immunology 89, SE111-SE111 (1996)
159. McMichael, A., Rowlandjones, S., Klenerman, P., McAdam, S., Gotch, F., Phillips, R.,Nowak, M.: Epitope Variation and T-Cell Recognition. Journal of Cellular Biochemistry, 60-60 (1995)
160. McMichael, A.J.,Phillips, R.E.: Escape of human immunodeficiency virus from immune control. Annual Review of Immunology 15, 271-296 (1997)
161. McMichael, A.J.,Rowland-Jones, S.L.: Cellular immune responses to HIV. Nature 410, 980-7. (2001)
162. Mercado, R., Vijh, S., Allen, S.E., Kerksiek, K., Pilip, I.M.,Pamer, E.G.: Early programming of T cell populations responding to bacterial infection. J Immunol 165, 6833-9 (2000)
163. Miller, V.: Structured treatment interruptions in antiretroviral management of HIV-1. Curr Opin Infect Dis 14, 29-37. (2001)
164. Montaner, L.J.: Structured treatment interruptions to control HIV-1 and limit drug exposure. Trends Immunol 22, 92-6. (2001)
165. Moore, J.P., Trkola, A.,Dragic, T.: Co-receptors for HIV-1 entry. Curr Opin Immunol 9, 551-62 (1997)
166. Moskophidis, D., Battegay, M., van den Broek, M., Laine, E., Hoffmann-Rohrer, U.,Zinkernagel, R.M.: Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J Gen Virol 76, 381-91 (1995a)
167. Moskophidis, D., Battegay, M., van den Broek, M., Laine, E., Hoffmann-Rohrer, U.,Zinkernagel, R.M.: Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J Gen Virol 76, 381-91. (1995b)
168. Moskophidis, D.,Kioussis, D.: Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med 188, 223-32. (1998)
169. Moskophidis, D., Laine, E.,Zinkernagel, R.M.: Peripheral clonal deletion of antiviral memory CD8+ T cells. Eur J Immunol 23, 3306-11. (1993a)
170. Moskophidis, D., Lechner, F., Pircher, H.,Zinkernagel, R.M.: Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362, 758-61. (1993b)
171. Moskophidis, D., Lechner, F., Pircher, H.,Zinkernagel, R.M.: Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells [published erratum appears in Nature 1993 Jul 15;364(6434):262]. Nature 362, 758-61 (1993c)
172. Mullbacher, A.: The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J Exp Med 179, 317-21 (1994)
173. Murali-Krishna, K., Lau, L.L., Sambhara, S., Lemonnier, F., Altman, J., Ahmed, R.: Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286, 1377-81 (1999)
174. Nansen, A., Jensen, T., Christensen, J.P., Andreasen, S.O., Ropke, C., Marker, O.,Thomsen, A.R.: Compromised virus control and augmented perforin-mediated immunopathology in IFN-gamma-deficient mice infected with lymphocytic choriomeningitis virus. J Immunol 163, 6114-22. (1999)
175. Neumann, A.U., Lam, N.P., Dahari, H., Gretch, D.R., Wiley, T.E., Layden, T.J.,Perelson, A.S.: Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282, 103-7. (1998)
176. Northfield, J., Lucas, M., Jones, H., Young, N.T.,Klenerman, P.: Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD8 T cells correlates with ’memory inflation’ in human cytomegalovirus infection. Immunol Cell Biol 83, 182-8 (2005)
177. Nowak, M.: Hiv Mutation-Rate. Nature 347, 522-522 (1990)
178. Nowak, M.A.: Variability of Hiv Infections. Journal of Theoretical Biology 155, 1-20 (1992)
179. Nowak, M.A.: Immune-Responses Against Multiple Epitopes-a Theory For Immunodominance and Antigenic Variation. Seminars in Virology 7, 83-92 (1996)
180. Nowak, M.A., Anderson, R.M., McLean, A.R., Wolfs, T.F.W., Goudsmit, J.,May, R.M.: Antigenic Diversity Thresholds and the Development of Aids. Science 254, 963-969 (1991)
181. Nowak, M.A.,Bangham, C.R.: Population dynamics of immune responses to persistent viruses. Science 272, 74-9 (1996)
182. Nowak, M.A., Lloyd, A.L., Vasquez, G.M., Wiltrout, T.A., Wahl, L.M., Bischofberger, N., Williams, J., Kinter, A., Fauci, A.S., Hirsch, V.M.,Lifson, J.D.: Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol 71, 7518-25 (1997)
183. Nowak, M.A.,May, R.M.: Mathematical Biology of Hiv Infections-Antigenic Variation and Diversity Threshold. Mathematical Biosciences 106, 1-21 (1991)
184. Nowak, M.A.,May, R.M. Virus dynamics. Mathematical principles of immunology and virology.: Oxford University Press(2000)
185. Nowak, M.A., May, R.M., Phillips, R.E., Rowlandjones, S., Lalloo, D.G., McAdam, S., Klenerman, P., Koppe, B., Sigmund, K., Bangham, C.R.M., McMichael, A.J.: Antigenic Oscillations and Shifting Immunodominance in Hiv-1 Infections. Nature 375, 606-611 (1995a)
186. Nowak, M.A., May, R.M.,Sigmund, K.: Immune-Responses Against Multiple Epitopes. Journal of Theoretical Biology 175, 325-353 (1995b)
187. Ochsenbein, A.F., Karrer, U., Klenerman, P., Althage, A., Ciurea, A., Shen, H., Miller, J.F., Whitton, J.L., Hengartner, H.,Zinkernagel, R.M.: A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc Natl Acad Sci U S A 96, 9293-8 (1999)
188. Oehen, S., Waldner, H., Kundig, T.M., Hengartner, H.,Zinkernagel, R.M.: Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med 176, 1273-81 (1992)
189. Ogg, G.S., Jin, X., Bonhoeffer, S., Moss, P., Nowak, M.A., Monard, S., Segal, J.P., Cao, Y., Rowland-Jones, S.L., Hurley, A., Markowitz, M., Ho, D.D., McMichael, A.J.,Nixon, D.F.: Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol 73, 797-800 (1999)
190. Oldstone, M.B., Salvato, M., Tishon, A.,Lewicki, H.: Virus-lymphocyte interactions. III. Biologic parameters of a virus variant that fails to generate CTL and establishes persistent infection in immunocompetent hosts. Virology 164, 507-16 (1988)
191. Oldstone, M.B., Sinha, Y.N., Blount, P., Tishon, A., Rodriguez, M., von Wedel, R.,Lampert, P.W.: Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. Science 218, 1125-7. (1982)
192. Ortiz, G.M., Hu, J., Goldwitz, J.A., Chandwani, R., Larsson, M., Bhardwaj, N., Bonhoeffer, S., Ramratnam, B., Zhang, L., Marko-witz, M.M., Nixon, D.F.: Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection. J Virol 76, 411-5. (2002)
193. Ortiz, G.M., Nixon, D.F., Trkola, A., Binley, J., Jin, X., Bonhoeffer, S., Kue-bler, P.J., Donahoe, S.M., Demoitie, M.A., Kakimoto, W.M., Ketas, T., Clas, B., Heymann, J.J., Zhang, L., Cao, Y., Hurley, A., Moore, J.P., Ho, D.D.,Markowitz, M.: HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J Clin Invest 104, R13-8 (1999)
194. Ortiz, G.M., Wellons, M., Brancato, J., Vo, H.T., Zinn, R.L., Clarkson, D.E., Van Loon, K., Bonhoeffer, S., Miralles, G.D., Montefiori, D., Bartlett, J.A.,Nixon, D.F.: Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc Natl Acad Sci U S A 98, 13288-93. (2001)
195. Oxenius, A., Price, D.A., Gunthard, H.F., Dawson, S.J., Fagard, C., Perrin, L., Fischer, M., Weber, R., Plana, M., Garcia, F., Hirschel, B., McLean, A.,Phillips, R.E.: Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Proc Natl Acad Sci U S A 99, 13747-52 (2002)
196. Perelson, A.S.: Modelling viral and immune system dynamics. Nature Rev Immunol 2, 28-36. (2002)
197. Perelson, A.S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M.,Ho, D.D.: Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188-91. (1997)
198. Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M.,Ho, D.D.: Hiv-1 Dynamics in-Vivo-Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time. Science 271, 1582-1586 (1996)
199. Pevear, D.C., Tull, T.M., Seipel, M.E.,Groarke, J.M.: Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother 43, 2109-15. (1999)
200. Phillips, R.E., Rowland-Jones, S., Nixon, D.F., Gotch, F.M., Edwards, J.P., Ogunlesi, A.O., Elvin, J.G., Rothbard, J.A., Bangham, C.R., Rizza, C.R.,et al.: Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-9 (1991) hskip-1.0cm
201. Pier, G.B., Lyczak, J.B., Wetzler, L.M.Immunology, Infection, and Immunity. Washington D.C.: ASM Press(2004)
202. Planz, O., Ehl, S., Furrer, E., Horvath, E., Brundler, M.A., Hengartner, H.,Zinkernagel, R.M.: A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci U S A 94, 6874-9 (1997)
203. Pontisso, P., Bellati, G., Brunetto, M., Chemello, L., Colloredo, G., Di Stefano, R., Nicoletti, M., Rumi, M.G., Ruvoletto, M.G., Soffredini, R., Valenza, L.M.,Colucci, G.: Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity? Hepatology 29, 585-9. (1999)
204. Price, D.A., Goulder, P.J., Klenerman, P., Sewell, A.K., Easterbrook, P.J., Troop, M., Bangham, C.R.,Phillips, R.E.: Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A 94, 1890-5 (1997a)
205. Price, D.A., Goulder, P.J.R., Klenerman, P., Sewell, A.K., Easterbrook, P.J., Troop, M., Bangham, C.R.M.,Phillips, R.E.: Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proceedings of the National Academy of Sciences of the United States of America 94, 1890-1895 (1997b)
206. Price, D.A., O’Callaghan C, A., Whelan, J.A., Easterbrook, P.J.,Phillips, R.E.: Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection. Clin Sci (Colch) 97, 707-18. (1999)
207. Puoti, C., Stati, T.,Magrini, A.: Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels. Liver 19, 104-9. (1999)
208. Quinnan, G.V., Manischewitz, J.E.,Ennis, P.A.: Role of cytotoxic T lymphocytes in murine cytomegalovirus infection. J Gen Virol 47, 503-8 (1980)
209. Reddehase, M.J., Podlech, J.,Grzimek, N.K.: Mouse models of cytomegalovirus latency: overview. J Clin Virol 25 Suppl 2, S23-36 (2002)
210. Regoes, R.R., Wodarz, D.,Nowak, M.A.: Virus dynamics: the effect of target cell limitation and immune responses on virus evolution. J Theor Biol 191, 451-62 (1998)
211. Reusser, P., Cathomas, G., Attenhofer, R., Tamm, M.,Thiel, G.: Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load. J Infect Dis 180, 247-53 (1999)
212. Ribeiro, R.M.,Bonhoeffer, S.: Production of resistant HIV mutants during antiretroviral therapy. Proc Natl Acad Sci U S A 97, 7681-6 (2000)
213. Ribeiro, R.M., Bonhoeffer, S.,Nowak, M.A.: The frequency of resistant mutant virus before antiviral therapy. Aids 12, 461-5 (1998)
214. Richman, D.D.: Drug resistance in viruses. Trends Microbiol 2, 401-7 (1994)
215. Richman, D.D.: Antiretroviral drug resistance: mechanisms, pathogenesis, clinical significance. Adv Exp Med Biol 394, 383-95 (1996)
216. Richman, D.D.: How drug resistance arises. Sci Am 279, 88. (1998)
217. Ridge, J.P., Di Rosa, F.,Matzinger, P.: A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393, 474-8 (1998)
218. Rosenberg, E.S., Altfeld, M., Poon, S.H., Phillips, M.N., Wilkes, B.M., El-dridge, R.L., Robbins, G.K., D’Aquila, R.T., Goulder, P.J., Walker, B.D.: Immune control of HIV-1 after early treatment of acute infection. Nature 407, 523-6 (2000)
219. Rosenberg, E.S., Billingsley, J.M., Caliendo, A.M., Boswell, S.L., Sax, P.E., Kalams, S.A.,Walker, B.D.: Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447-50 (1997)
220. Rosenberg, E.S., LaRosa, L., Flynn, T., Robbins, G.,Walker, B.D.: Characterization of HIV-1-specific T-helper cells in acute and chronic infection. Immunol Lett 66, 89-93 (1999)
221. Rosenberg, E.S.,Walker, B.D.: HIV type 1-specific helper T cells: a critical host defense. AIDS Res Hum Retroviruses 14 Suppl 2, S143-7 (1998)
222. Rouse, B.T.,Deshpande, S.: Viruses and autoimmunity: an affair but not a marriage contract. Rev Med Virol 12, 107-13. (2002)
223. Rudensey, L.M., Kimata, J.T., Benveniste, R.E.,Overbaugh, J.: Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology 207, 528-42 (1995)
224. Saag, M.S., Hahn, B.H., Gibbons, J., Li, Y.X., Parks, E.S., Parks, W.P.,Shaw, G.M.: Extensive Variation of Human Immunodeficiency Virus Type-1 In-vivo. Nature 334, 440-444 (1988)
225. Saah, A.J., Hoover, D.R., Weng, S., Carrington, M., Mellors, J., Rinaldo, C.R., Jr., Mann, D., Apple, R., Phair, J.P., Detels, R., O’Brien, S., Enger, C., Johnson, P.,Kaslow, R.A.: Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study. Aids 12, 2107-13 (1998)
226. Sallusto, F.,Lanzavecchia, A.: Exploring pathways for memory T cell generation. J Clin Invest 108, 805-6 (2001)
227. Sarawar, S.R., Lee, B.J., Reiter, S.K.,Schoenberger, S.P.: Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus. Proc Natl Acad Sci U S A 98, 6325-9. (2001)
228. Scarlatti, G., Tresoldi, E., Bjorndal, A., Fredriksson, R., Colognesi, C., Deng, H.K., Malnati, M.S., Plebani, A., Siccardi, A.G., Littman, D.R., Fenyo, E.M.,Lusso, P.: In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 3, 1259-65 (1997)
229. Schmitz, J.E., Kuroda, M.J., Santra, S., Sasseville, V.G., Simon, M.A., Lifton, M.A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B.J., Ghrayeb, J., Forman, M.A., Montefiori, D.C., Rieber, E.P., Letvin, N.L.,Reimann, K.A.: Control of viremia in simian immunodeficiency virus infection by CD8(+) lymphocytes. Science 283, 857-60 (1999)
230. Schoenberger, S.P., Toes, R.E., van der Voort, E.I., Offringa, R.,Melief, C.J.: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-3 (1998)
231. Scholz, M., Doerr, H.W.,Cinatl, J.: Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option? Antiviral Res 49, 129-45 (2001)
232. Seewaldt, S., Thomas, H.E., Ejrnaes, M., Christen, U., Wolfe, T., Rodrigo, E., Coon, B., Michelsen, B., Kay, T.W.,von Herrath, M.G.: Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 49, 1801-9. (2000)
233. Selin, L.K., Lin, M.Y., Kraemer, K.A., Pardoll, D.M., Schneck, J.P., Varga, S.M., Santolucito, P.A., Pinto, A.K.,Welsh, R.M.: Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11, 733-42 (1999)
234. Selin, L.K., Vergilis, K., Welsh, R.M.,Nahill, S.R.: Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med 183, 2489-99 (1996)
235. Shedlock, D.J.,Shen, H.: Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300, 337-9 (2003)
236. Sierro, S., Rothkopf, R.,Klenerman, P.: Evolution of diverse antiviral CD8+ T cell populations after murine cytomegalovirus infection. Eur J Immunol 35, 1113-23 (2005)
237. Silvestri, G., Fedanov, A., Germon, S., Kozyr, N., Kaiser, W.J., Garber, D.A., McClure, H., Feinberg, M.B.,Staprans, S.I.: Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J Virol 79, 4043-54 (2005)
238. Slifka, M.K.,Ahmed, R.: Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol 10, 252-8 (1998)
239. Stepp, S.E., Mathew, P.A., Bennett, M., de Saint Basile, G.,Kumar, V.: Perforin: more than just an effector molecule. Immunol Today 21, 254-6. (2000)
240. Stevenson, M.: Identification of factors that govern HIV-1 replication in nondividing host cells. AIDS Res Hum Retroviruses 10 Suppl 1, S11-5 (1994)
241. Stevenson, M.: Pathway to understanding AIDS. Nature Structural Biology 3, 303-306 (1996)
242. Stevenson, M., Brichacek, B., Heinzinger, N., Swindells, S., Pirruccello, S., Janoff, E.,Emerman, M.: Molecular basis of cell cycle dependent HIV-1 replication. Implications for control of virus burden. Adv Exp Med Biol 374, 33-45 (1995)
243. Sun, J.C.,Bevan, M.J.: Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300, 339-42 (2003)
244. Sun, J.C., Williams, M.A.,Bevan, M.J.: CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol 5, 927-33 (2004)
245. Swain, S.L.: Regulation of the generation and maintenance of T-cell memory: a direct, default pathway from effectors to memory cells. Microbes Infect 5, 213-9 (2003)
246. Tersmette, M., Lange, J.M., de Goede, R.E., de Wolf, F., Eeftink-Schattenkerk, J.K., Schellekens, P.T., Coutinho, R.A., Huisman, J.G., Goudsmit, J., Miedema, F.: Association between biological properties of human immun odeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1, 983-5 (1989)
247. Thimme, R., Oldach, D., Chang, K.M., Steiger, C., Ray, S.C.,Chisari, F.V.: Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194, 1395-406. (2001)
248. Thomsen, A.R., Johansen, J., Marker, O.,Christensen, J.P.: Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J Immunol 157, 3074-80 (1996)
249. Thomsen, A.R.,Marker, O.: The complementary roles of cellular and humoral immunity in resistance to re-infection with LCM virus. Immunology 65, 9-15 (1988)
250. Thomsen, A.R., Nansen, A., Andersen, C., Johansen, J., Marker, O.,Christensen, J.P.: Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus. Int Immunol 9, 1757-66 (1997)
251. Thomsen, A.R., Nansen, A., Andreasen, S.O., Wodarz, D.,Christensen, J.P.: Host factors influencing viral persistence. Phil. Trans. Roy. Soc. Lond. B 355, 1031-1041 (2000)
252. Thomsen, A.R., Nansen, A., Christensen, J.P., Andreasen, S.O.,Marker, O.: CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. J Immunol 161, 4583-90 (1998)
253. Thomson, M., Nascimbeni, M., Gonzales, S., Murthy, K.K., Rehermann, B.,Liang, T.J.: Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus. Gastroenterology 121, 1226-33. (2001)
254. Thorley-Lawson, D.A.,Babcock, G.J.: A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. Life Sci 65, 1433-53 (1999)
255. Topham, D.J., Tripp, R.A.,Doherty, P.C.: CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 159, 5197-200 (1997)
256. Topham, D.J., Tripp, R.A., Hamilton-Easton, A.M., Sarawar, S.R., Doherty, P.C.: Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig. J Immunol 157, 2947-52. (1996)
257. Tripp, R.A., Sarawar, S.R.,Doherty, P.C.: Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-2lAb gene. J Immunol 155, 2955-9 (1995)
258. Urbain, J.: Idiotypic networks: a noisy background or a breakthrough in immunological thinking? The broken mirror hypothesis. Ann Inst Pasteur Immunol 137C, 57-64 (1986)
259. van den Broek, M.F., Muller, U., Huang, S., Aguet, M.,Zinkernagel, R.M.: Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol 69, 4792-6. (1995a)
260. van den Broek, M.F., Muller, U., Huang, S., Zinkernagel, R.M.,Aguet, M.: Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev 148, 5-18. (1995b)
261. van Stipdonk, M.J., Hardenberg, G., Bijker, M.S., Lemmens, E.E., Droin, N.M., Green, D.R.,Schoenberger, S.P.: Dynamic programming of CD8+ T lymphocyte responses. Nat Immunol 4, 361-5 (2003)
262. van Stipdonk, M.J., Lemmens, E.E.,Schoenberger, S.P.: Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2, 423-9. (2001)
263. van’t Wout, A.B., Kootstra, N.A., Mulder-Kampinga, G.A., Albrecht-van Lent, N., Scherpbier, H.J., Veenstra, J., Boer, K., Coutinho, R.A., Miedema, F.,Schuitemaker, H.: Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 94, 2060-7 (1994)
264. Veiga-Fernandes, H., Walter, U., Bourgeois, C., McLean, A.,Rocha, B.: Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat Immunol 1, 47-53 (2000)
265. Villarete, L., Somasundaram, T.,Ahmed, R.: Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells. J Virol 68, 7490-6. (1994)
266. Wahl, L.M.,Nowak, M.A.: Adherence and drug resistance: predictions for therapy outcome. Proc R Soc Lond B Biol Sci 267, 835-43 (2000)
267. Wei, X., Decker, J.M., Wang, S., Hui, H., Kappes, J.C., Wu, X., Salazar-Gonzalez, J.F., Salazar, M.G., Kilby, J.M., Saag, M.S., Komarova, N.L., Nowak, M.A., Hahn, B.H., Kwong, P.D.,Shaw, G.M.: Antibody neutralization and escape by HIV-1. Nature 422, 307-12 (2003)
268. Wei, X.P., Ghosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A., Deutsch, P., Lifson, J.D., Bonhoeffer, S., Nowak, M.A., Hahn, B.H., Saag, M.S.,Shaw, G.M.: Viral Dynamics in Human Immunodeficiency Virus Type-1 Infection. Nature 373, 117-122 (1995)
269. Weiner, A.J., Geysen, H.M., Christopherson, C., Hall, J.E., Mason, T.J., Saracco, G., Bonino, F., Crawford, K., Marion, C.D., Crawford, K.A.,et al.: Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 89, 3468-72. (1992)
270. Welsh, R.M., Selin, L.K.,Razvi, E.S.: Role of apoptosis in the regulation of virus-induced T cell responses, immune suppression, and memory. J Cell Biochem 59, 135-42 (1995)
271. Weninger, W., Manjunath, N.,von Andrian, U.H.: Migration and differentiation of CD8+ T cells. Immunol Rev 186, 221-33. (2002)
272. Wherry, E.J., Blattman, J.N., Murali-Krishna, K., van der Most, R., Ahmed, R.: Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77, 4911-27 (2003a)
273. Wherry, E.J., Teichgraber, V., Becker, T.C., Masopust, D., Kaech, S.M., Antia, R., von Andrian, U.H., Ahmed, R.: Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4, 225-34 (2003b)
274. Wodarz, D.: Cytotoxic T-lymphocyte memory, virus clearance and antigenic heterogeneity. Proc Biol Sci 268, 429-36 (2001a)
275. Wodarz, D.: Mechanisms underlying antigen-specific CD8+ T cell homeostasis. Science 292, 595. (2001b)
276. Wodarz, D.: Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses. J Gen Virol 84, 1743-50 (2003)
277. Wodarz, D., Arnaout, R.A., Nowak, M.A.,Lifson, J.D.: Transient antiretroviral treatment during acute SIV infection facilitates long-term control of the virus. Phil. Trans. Roy. Soc. Lond. B 355, 1021-1029 (2000a)
278. Wodarz, D., Christensen, J.P.,Thomsen, A.R.: The importance of lytic and nonlytic immune responses in viral infections. Trends Immunol 23, 194-200. (2002)
279. Wodarz, D., Hall, S.E., Usuku, K., Osame, M., Ogg, G.S., McMichael, A.J., Nowak, M.A.,Bangham, C.R.: Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc R Soc Lond B Biol Sci 268, 1215-21. (2001)
280. Wodarz, D., Klenerman, P.,Nowak, M.A.: Dynamics of cytotoxic T-lymphocyte exhaustion. Proc R Soc Lond B Biol Sci 265, 191-203 (1998)
281. Wodarz, D.,Krakauer, D.C.: Defining CTL-induced pathology: implications for HIV. Virology 274, 94-104. (2000)
282. Wodarz, D., Lloyd, A.L., Jansen, V.A.A.,Nowak, M.A.: Dynamics of macrophage and T cell infection by HIV. Journal of Theoretical Biology 196, 101-113 (1999)
283. Wodarz, D., May, R.M.,Nowak, M.A.: The role of antigen-independent persistence of memory CTL. International Immunology 12, 467-477 (2000b)
284. Wodarz, D.,Nowak, M.A.: Specific therapy regimes could lead to long-term control of HIV. Proc. Natl. Acad. Sci. USA 96, 14464-14469 (1999)
285. Wodarz, D.,Nowak, M.A.: CD8 memory, immunodominance and antigenic escape. Europ. J. Immunol. 30, 2704-2712 (2000a)
286. Wodarz, D.,Nowak, M.A.: Immune responses and viral phenotype: do replication rate and cytopathogenicity influence virus load? Journal of Theoretical Medicine 2, 113-127 (2000b)
287. Wodarz, D., Page, K.M., Arnaout, R.A., Thomsen, A.R., Lifson, J.D., Nowak, M.A.: A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment. Philos Trans R Soc Lond B Biol Sci 355, 329-43 (2000c)
288. Wodarz, D.,Thomsen, A.R.: Does programmed CTL proliferation optimize virus control? Trends Immunol 26, 305-10 (2005)
289. Wolinsky, S.M., Korber, B.T., Neumann, A.U., Daniels, M., Kunstman, K.J., Whetsell, A.J., Furtado, M.R., Cao, Y., Ho, D.D.,Safrit, J.T.: Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272, 537-42 (1996)
290. Wong, J.K., Hezareh, M., Gunthard, H.F., Havlir, D.V., Ignacio, C.C., Spina, C.A.,Richman, D.D.: Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291-5 (1997)
291. Xiang, R., Lode, H.N., Gillies, S.D.,Reisfeld, R.A.: T cell memory against colon carcinoma is long-lived in the absence of antigen. J Immunol 163, 3676-83 (1999)
292. Yewdell, J.W.,Bennink, J.R.: Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 17, 51-88 (1999)
293. Zhang, L., Yu, W., He, T., Yu, J., Caffrey, R.E., Dalmasso, E.A., Fu, S., Pham, T., Mei, J., Ho, J.J., Zhang, W., Lopez, P.,Ho, D.D.: Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298, 995-1000 (2002)
294. Zimmerman, C., Brduscha-Riem, K., Blaser, C., Zinkernagel, R.M., Pircher, H.: Visualization, characterization, and turnover of CD8 memory T cells in virus-infected hosts. J Exp Med 183, 1367-75 (1996)
295. Zinkernagel, R.: [Virus-induced immune deficiency disease AIDS: direct pathogenic effect of the virus or immunopathology?]. Verh Dtsch Ges Pathol 78, 166-70 (1994)
296. Zinkernagel, R.M.: Immune protection vs. immunopathology vs. autoimmunity: a question of balance and of knowledge. Brain Pathol 3, 115-21 (1993)
297. Zinkernagel, R.M.: Immunosuppression by a noncytolytic virus via T cell mediated immunopathology. Implication for AIDS. Adv Exp Med Biol 374, 165-71 (1995)
298. Zinkernagel, R.M.: Immunology taught by viruses. Science 271, 173-8 (1996)
299. Zinkernagel, R.M.: On immunological memory. Philos Trans R Soc Lond B Biol Sci 355, 369-71. (2000a)
300. Zinkernagel, R.M.: What is missing in immunology to understand immunity? Nat Immunol 1, 181-5. (2000b)
301. Zinkernagel, R.M.: On differences between immunity and immunological memory. Curr Opin Immunol 14, 523-36. (2002a)
302. Zinkernagel, R.M.: Uncertainties-discrepancies in immunology. Immunol Rev 185, 103-25. (2002b)
303. Zinkernagel, R.M., Althage, A.,Jensen, F.C.: Cell-mediated immune response to lymphocytic choriomeningitis and vaccinia virus in rats. J Immunol 119, 1242-7. (1977)
304. Zinkernagel, R.M.,Hengartner, H.: T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today 15, 262-8 (1994)
305. Zinkernagel, R.M., Planz, O., Ehl, S., Battegay, M., Odermatt, B., Klenerman, P.,Hengartner, H.: General and specific immunosuppression caused by antiviral T-cell responses. Immunol Rev 168, 305-15 (1999)